Insider Transactions in Q2 2022 at Navidea Biopharmaceuticals, Inc. (NAVB)
Insider Transaction List (Q2 2022)
Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
---|---|---|---|---|---|
Jun 30
2022
|
Alexander L Cappello Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,500
+4.24%
|
-
|
Jun 30
2022
|
Amit Bhalla Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,500
+3.96%
|
-
|
Jun 30
2022
|
Malcolm G Witter Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,500
+1.6%
|
-
|
Jun 30
2022
|
John K Scott Jr. |
BUY
Grant, award, or other acquisition
|
Direct |
2,500
+0.03%
|
-
|
May 31
2022
|
Amit Bhalla Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,500
+4.13%
|
-
|
May 31
2022
|
Alexander L Cappello Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,500
+4.43%
|
-
|
May 31
2022
|
John K Scott Jr. |
BUY
Grant, award, or other acquisition
|
Direct |
2,500
+0.03%
|
-
|
May 31
2022
|
Malcolm G Witter Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,500
+1.62%
|
-
|
Apr 30
2022
|
Amit Bhalla Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,500
+4.31%
|
-
|
Apr 30
2022
|
Alexander L Cappello Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,500
+4.63%
|
-
|
Apr 30
2022
|
Malcolm G Witter Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,500
+1.65%
|
-
|
Apr 30
2022
|
John K Scott Jr. |
BUY
Grant, award, or other acquisition
|
Direct |
2,500
+0.03%
|
-
|
Apr 10
2022
|
John K Scott Jr. |
BUY
Open market or private purchase
|
Direct |
3,260
+50.0%
|
-
|